International Journal of Chronic Obstructive Pulmonary Disease

Scope & Guideline

Pioneering Insights into Chronic Obstructive Pulmonary Disease

Introduction

Welcome to your portal for understanding International Journal of Chronic Obstructive Pulmonary Disease, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1178-2005
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2006 to 2024
AbbreviationINT J CHRONIC OBSTR / Int. J. Chronic Obstr. Pulm. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The International Journal of Chronic Obstructive Pulmonary Disease primarily focuses on advancing research related to chronic obstructive pulmonary disease (COPD), with a strong emphasis on clinical studies, epidemiology, and innovative therapeutic approaches.
  1. Clinical Management and Treatment Strategies:
    The journal publishes studies that explore various management strategies for COPD, including pharmacological treatments, inhalation therapies, and non-pharmacological interventions such as pulmonary rehabilitation.
  2. Epidemiology and Risk Factors:
    Research focusing on the prevalence, risk factors, and comorbidities associated with COPD is a key area of interest, providing valuable insights into the disease's impact on diverse populations.
  3. Pathophysiology and Mechanisms:
    The journal emphasizes studies that investigate the underlying mechanisms of COPD, including inflammatory pathways, genetic factors, and the role of the microbiome in disease progression.
  4. Quality of Life and Patient-Centered Approaches:
    Articles addressing the quality of life in COPD patients, including psychological aspects such as anxiety and depression, and the effectiveness of patient education and self-management strategies are commonly featured.
  5. Innovative Technologies and Interventions:
    The journal is open to research on new technologies, such as telemedicine, digital health solutions, and novel pharmacological agents that aim to improve patient outcomes and disease management.
Recent publications in the International Journal of Chronic Obstructive Pulmonary Disease indicate several emerging themes that are gaining traction within the field.
  1. Integration of Digital Health Solutions:
    The rise of digital health technologies, including telehealth and mobile health applications, is becoming a central theme, reflecting a shift towards remote monitoring and management of COPD.
  2. Comorbidity Research:
    There is an increasing focus on the interplay between COPD and other chronic conditions, such as cardiovascular diseases and metabolic syndromes, highlighting the importance of integrated care approaches.
  3. Patient-Centered Outcomes and Quality of Life:
    Research emphasizing patient-reported outcomes, quality of life assessments, and psychosocial factors in COPD management is trending, indicating a growing recognition of the holistic nature of care.
  4. Biomarkers and Personalized Medicine:
    Studies exploring biomarkers for diagnosis, prognosis, and treatment responses are on the rise, representing a shift towards personalized medicine approaches in COPD management.
  5. Environmental and Lifestyle Factors:
    Emerging research is increasingly addressing the impact of environmental exposures, dietary habits, and lifestyle modifications on COPD development and management.

Declining or Waning

As the field of COPD research evolves, certain themes have shown a decline in focus within the journal's recent publications.
  1. Traditional Pharmacological Therapies:
    There has been a noticeable reduction in studies focused solely on traditional pharmacological therapies, such as oral corticosteroids, as newer therapeutic approaches gain prominence.
  2. Surgery and Invasive Procedures:
    Research related to surgical interventions for COPD, such as lung volume reduction surgery, appears to have decreased, likely due to a growing preference for less invasive management options.
  3. Basic Science Research:
    While fundamental research into COPD pathophysiology remains important, the journal has seen fewer basic science studies compared to clinical and translational research, reflecting a shift towards more applied investigations.

Similar Journals

EUROPEAN RESPIRATORY JOURNAL

Championing Breakthroughs in Lung Health
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

RESPIRATORY MEDICINE

Championing Excellence in Pulmonary Research
Publisher: W B SAUNDERS CO LTDISSN: 0954-6111Frequency: 12 issues/year

Respiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.

Pulmonary Therapy

Elevating pulmonary medicine with open-access insights.
Publisher: SPRINGERNATUREISSN: 2364-1754Frequency: 2 issues/year

Pulmonary Therapy is a leading open-access journal published by SpringerNature, dedicated to advancing the field of pulmonary and respiratory medicine as well as respiratory care. Established in 2015 and situated in the United Kingdom, the journal has rapidly gained recognition, evidenced by its impressive Q2 quartile rankings in both the Pulmonary and Respiratory Medicine and Respiratory Care categories as of 2023. With a focus on innovative research, the journal provides a platform for the dissemination of high-quality studies that address critical issues in respiratory health. Leveraging the open access model, it ensures wide dissemination and accessibility of knowledge amongst researchers, healthcare professionals, and students, thereby fostering collaborative advancements in treatment approaches and preventive care strategies. As the field continues to evolve, Pulmonary Therapy remains committed to publishing impactful scientific contributions that shape the future of respiratory medicine.

Pulmonary Medicine

Advancing the Frontiers of Respiratory Health
Publisher: HINDAWI LTDISSN: 2090-1836Frequency: 1 issue/year

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

Minerva Respiratory Medicine

Exploring the frontiers of pulmonary medicine.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Multidisciplinary Respiratory Medicine

Championing open access to vital respiratory findings.
Publisher: MATTIOLI 1885ISSN: 1828-695XFrequency: 1 issue/year

Multidisciplinary Respiratory Medicine is a leading open-access journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by MATTIOLI 1885, this journal has been serving the academic community since 2008 and has become a vital platform for the dissemination of research and clinical insights in this critical area of healthcare. With an impressive impact factor placing it in the Q2 category of pulmonary medicine in 2023 and a Scopus rank of #67 out of 155, it reflects a solid commitment to high-quality research. The journal provides researchers, health professionals, and students with accessible and updated information, fostering collaboration and advancement in respiratory health. Operating from the United Kingdom, it has embraced open access since 2010, ensuring that all articles are freely available, thus maximizing the reach and impact of its scholarly contributions. Whether you are looking to publish innovative findings or gain insights from industry leaders, Multidisciplinary Respiratory Medicine is your go-to resource for the latest in respiratory science.

Annals of Physical and Rehabilitation Medicine

Exploring New Frontiers in Physical Medicine and Recovery
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 1877-0657Frequency: 6 issues/year

Annals of Physical and Rehabilitation Medicine, published by Elsevier France-Editions Scientifiques Medicales Elsevier, stands as a leading peer-reviewed journal in the fields of Orthopedics and Rehabilitation. With its ISSN 1877-0657 and E-ISSN 1877-0665, this esteemed journal is known for its high-quality research articles that significantly influence clinical practices and advancements in rehabilitation medicine. Recognized for its impact, the journal is categorized in the Q1 quartiles for both Orthopedics and Sports Medicine as well as Rehabilitation disciplines. According to the Scopus rankings, it ranks #5 out of 161 in Rehabilitation and #20 out of 321 in Orthopedics and Sports Medicine, illustrating its critical role in shaping the future of these fields with a remarkable 97th and 93rd percentile standing respectively. With a commitment to excellence, the journal publishes innovative research that addresses the evolving needs of both practitioners and patients, making it an essential resource for researchers, professionals, and students dedicated to improving rehabilitation practices. The journal operates under conventional access options, ensuring that its groundbreaking findings remain accessible to a wide audience.

RESPIRATION

Publishing Insights that Shape Respiratory Medicine
Publisher: KARGERISSN: 0025-7931Frequency: 12 issues/year

RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

Therapeutic Advances in Respiratory Disease

Empowering Progress in Respiratory Disease Management
Publisher: SAGE PUBLICATIONS LTDISSN: 1753-4658Frequency: 1 issue/year

Therapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.

Indian Journal of Respiratory Care

Advancing Respiratory Health Through Open Access Research
Publisher: JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTDISSN: 2277-9019Frequency: 4 issues/year

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.